Phase II Study to Evaluate the Cardiac Safety of 2 Doses of CHF5993 Both Combined With CHF1535 BID Versus CHF1535 BID in Patients With Moderate to Severe COPD
Study Identifier:
CCD-1107-PR-0067
ClinicalTrials.gov Identifier:
EudraCT Identifier:
Study Contact Information:
N/A
Study Complete
Study Details
Medical Condition
- Chronic Obstructive Pulmonary Disease
Study Drug
- Drug: CHF1535 + CHF5992 dose 1 BID
- Drug: CHF1535 + CHF5992 dose2 BID
- Drug: CHF1535 daily dose
Date
Apr 2012 - Sep 2012
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 40 - 80 Years
Requirements Information
Healthy Volunteers
No
Protocol Summary
Cardiac Safety Study
Study Locations
Location
Status
Location
Hospital "Lozenets"
Sofia, Bulgaria, 1407
Status
N/A
Location
Praxis Dr. Kampschulte
Berlin, Germany, D-12165
Status
N/A
Location
Fővárosi Önkormányzat Szent János Kórháza és Észak-budai Egyesített Kórházai Tüdőgondozó Szakrendelő
Budapest, Hungary, 1122
Status
N/A
Location
ISPL Centrum Medyczne Robert M. Mróz
Białystok, Poland, 15-003
Status
N/A
Location
State Budgetary Healthcare Institution of Moscow city
Moscow, Russian Federation, 127018
Status
N/A
Location
Medicines Evaluation Unit, Langley Building
Manchester, United Kingdom, M23 9QZ
Status
N/A